Pharmacology

rheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospitalrheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospital

rheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospitalrheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospital

rheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospitalrheumatoid arthritis, RA, psoriasis, diabetes, insulin resistance, disease-modifying antirheumatic drugs, DMARDs, tumor necrosis factor inhibitors, TNF, hydroxychloroquine, diabetes mellitus, DM, Brigham and Women's Hospital

levothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosislevothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosis

levothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosislevothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosis

levothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosislevothyroxtine, hypothyroidism, University of Toronto, seizure, trauma, cancer, fracture, cardia arrhythmia, dementia, serotonin reuptake inhibitors, osteoporosis

essential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hbessential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hb

essential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hbessential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hb

essential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hbessential amino acids, EAAs, geriatric patients, Istituto Geriatrico Piero Redaelli, maltodextrine, nonreactant proteins, blood urea nitrogen, serum creatine levels, C-reactive protein, CRP, hemoglobin, Hb

antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin

antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin

antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin antihypoglycemic agent, metformin-plus-sulfonylurea therapy, Universidade Federal do Rio Grande do Sul, Federal University of Rio Grande do Sul, acarbose, thiazolidinediones, glucagon-like peptide-1 agonists, GLP-1, dipeptidyl peptidase-4 inhibitors, DPP-4, insulin

caffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasoundcaffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasound

caffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasoundcaffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasound

caffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasoundcaffeine, brachial endothelial function, coronary artery disease, Sheba Medical Center, high-sensitivity C-reactive protein, hs-CRP, serum adiponectin, brachial artery flow-mediated dilated, FMD, nitroglycerin-mediated dilation, NTG, high-resolution ultrasound

corticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFAcorticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFA

corticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFAcorticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFA

corticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFAcorticosteroids, mortality rates, community-acquired pneumonia, CAP, Barra D'Or Hospital, Garcia de Ortz Hospital, bronchospasm, septic shock, C-reactive protein, CRP, chronic obstructive pulmonary disease, Acute Physiology and Chronic Health Evaluation II, APACHE, Sequential Organ Failure Assessment, SOFA

nonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertensionnonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertension

nonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertensionnonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertension

nonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertensionnonsteroidal anti-inflammatory drugs, NSAIDs, osteoarthritis, increased blood pressure, BP, naproxcinod, naproxen, renin-angiotensin system inhibitors, RAS, vascular disease, hypertension

Cyclosporin A, CyA, ulcerative colitis, Cambridge University Hospitals National Health Service Foundation Trust, United Kingdom, colectomy, intravenous steroids, steroidrefractory flareCyclosporin A, CyA, ulcerative colitis, Cambridge University Hospitals National Health Service Foundation Trust, United Kingdom, colectomy, intravenous steroids, steroidrefractory flare

Cyclosporin A, CyA, ulcerative colitis, Cambridge University Hospitals National Health Service Foundation Trust, United Kingdom, colectomy, intravenous steroids, steroidrefractory flareCyclosporin A, CyA, ulcerative colitis, Cambridge University Hospitals National Health Service Foundation Trust, United Kingdom, colectomy, intravenous steroids, steroidrefractory flare

Cyclosporin A, CyA, ulcerative colitis, Cambridge University Hospitals National Health Service Foundation Trust, United Kingdom, colectomy, intravenous steroids, steroidrefractory flareCyclosporin A, CyA, ulcerative colitis, Cambridge University Hospitals National Health Service Foundation Trust, United Kingdom, colectomy, intravenous steroids, steroidrefractory flare

elderly patients, advanced cancer, chemotherapy, life-extending treatment, life-enhancing treatment, National Federation of Centers Fighting Cancer, Paris, 5-Fluorouracil, 5-FU, metastatic colorectal cancer, mCRC, capecitabine-oxaliplatin, XELOX, capecitabine, oxaliplatin, Katz Activities of Daily Living scale, ADL scaleelderly patients, advanced cancer, chemotherapy, life-extending treatment, life-enhancing treatment, National Federation of Centers Fighting Cancer, Paris, 5-Fluorouracil, 5-FU, metastatic colorectal cancer, mCRC, capecitabine-oxaliplatin, XELOX, capecitabine, oxaliplatin, Katz Activities of Daily Living scale, ADL scale

elderly patients, advanced cancer, chemotherapy, life-extending treatment, life-enhancing treatment, National Federation of Centers Fighting Cancer, Paris, 5-Fluorouracil, 5-FU, metastatic colorectal cancer, mCRC, capecitabine-oxaliplatin, XELOX, capecitabine, oxaliplatin, Katz Activities of Daily Living scale, ADL scaleelderly patients, advanced cancer, chemotherapy, life-extending treatment, life-enhancing treatment, National Federation of Centers Fighting Cancer, Paris, 5-Fluorouracil, 5-FU, metastatic colorectal cancer, mCRC, capecitabine-oxaliplatin, XELOX, capecitabine, oxaliplatin, Katz Activities of Daily Living scale, ADL scale

elderly patients, advanced cancer, chemotherapy, life-extending treatment, life-enhancing treatment, National Federation of Centers Fighting Cancer, Paris, 5-Fluorouracil, 5-FU, metastatic colorectal cancer, mCRC, capecitabine-oxaliplatin, XELOX, capecitabine, oxaliplatin, Katz Activities of Daily Living scale, ADL scaleelderly patients, advanced cancer, chemotherapy, life-extending treatment, life-enhancing treatment, National Federation of Centers Fighting Cancer, Paris, 5-Fluorouracil, 5-FU, metastatic colorectal cancer, mCRC, capecitabine-oxaliplatin, XELOX, capecitabine, oxaliplatin, Katz Activities of Daily Living scale, ADL scale

bacterial vaginosis, BV, birth complications, sexualy transmitted diseases, STDs, tinidazole, metronidazole, yeast infectionbacterial vaginosis, BV, birth complications, sexualy transmitted diseases, STDs, tinidazole, metronidazole, yeast infection

bacterial vaginosis, BV, birth complications, sexualy transmitted diseases, STDs, tinidazole, metronidazole, yeast infectionbacterial vaginosis, BV, birth complications, sexualy transmitted diseases, STDs, tinidazole, metronidazole, yeast infection

bacterial vaginosis, BV, birth complications, sexualy transmitted diseases, STDs, tinidazole, metronidazole, yeast infectionbacterial vaginosis, BV, birth complications, sexualy transmitted diseases, STDs, tinidazole, metronidazole, yeast infection